NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE137209 Query DataSets for GSE137209
Status Public on Sep 09, 2020
Title Bromodomain and HDAC inhibitors equivalently suppress PI3K/AKT inhibition resistance in cancers
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Sep 10, 2019
Last update date Sep 13, 2020
Contact name Zhenqing Ye
E-mail(s) [email protected]
Organization name UT Health San Antonio
Department 6Department of Population Health Sciences
Street address 8403 Floyd Curl Dr
City San Antonio
State/province TX
ZIP/Postal code 78229
Country USA
 
Platforms (2)
GPL20301 Illumina HiSeq 4000 (Homo sapiens)
GPL21290 Illumina HiSeq 3000 (Homo sapiens)
Samples (56)
GSM4072891 PC-3_control_Rep1
GSM4072892 PC-3_control_Rep2
GSM4072893 PC-3_control_Rep3
This SuperSeries is composed of the following SubSeries:
GSE137200 Pattern occupation of HDACs on chromatin determines PI3K/AKT inhibitor resistance in cancers [RNA-seq]
GSE137207 Pattern occupation of HDACs on chromatin determines PI3K/AKT inhibitor resistance in cancers [ChIP-seq]
GSE147455 An epigenetic vulnerability in PI3K/AKT inhibition resistant cancers is targetable by both bromodomain and HDAC inhibitors
Relations
BioProject PRJNA564805

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE137209_RAW.tar 9.1 Gb (http)(custom) TAR (of BW, XLS)
SRA Run SelectorHelp
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap